These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 35324674)

  • 1. The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.
    Cunha RSD; Azevedo CAB; Falconi CA; Ruiz FF; Liabeuf S; Carneiro-Ramos MS; Stinghen AEM
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.
    Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A
    NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailing Protein-Bound Uremic Toxin Interaction Mechanisms with Human Serum Albumin in the Pursuit of Designing Competitive Binders.
    Dehghan Niestanak V; Unsworth LD
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier perturbations by uremic toxins: Key contributors in chronic kidney disease-induced neurological disorders?
    Faucher Q; van der Made TK; De Lange E; Masereeuw R
    Eur J Pharm Sci; 2023 Aug; 187():106462. PubMed ID: 37169097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption- and Displacement-Based Approaches for the Removal of Protein-Bound Uremic Toxins.
    Rodrigues FSC; Faria M
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do Uremic Toxins Affect the Endothelium?
    Cunha RSD; Santos AF; Barreto FC; Stinghen AEM
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32575762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.
    Mihaila SM; Faria J; Stefens MFJ; Stamatialis D; Verhaar MC; Gerritsen KGF; Masereeuw R
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen-Immobilized Thin Films: A Novel Approach to Improve the Clearance of Protein-Bound Uremic Toxins.
    Rodrigues FSC; Brilhante D; MacĂȘdo A; Pires RF; Faria M
    ACS Appl Mater Interfaces; 2024 Feb; 16(5):6589-6604. PubMed ID: 38282580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence.
    Chen JH; Chiang CK
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
    Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
    Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia.
    Masereeuw R
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adsorption capacity of poly(ether imide) microparticles to uremic toxins.
    Tetali SD; Jankowski V; Luetzow K; Kratz K; Lendlein A; Jankowski J
    Clin Hemorheol Microcirc; 2016; 61(4):657-65. PubMed ID: 26639769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-Derived Protein-Bound Uremic Toxins.
    Graboski AL; Redinbo MR
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?
    Florens N; Yi D; Juillard L; Soulage CO
    Biochimie; 2018 Jan; 144():1-8. PubMed ID: 28987629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved dialytic removal of protein-bound uremic toxins by intravenous lipid emulsion in chronic kidney disease rats.
    Shi Y; Zhang Y; Tian H; Wang Y; Shen Y; Zhu Q; Ding F
    Nephrol Dial Transplant; 2019 Nov; 34(11):1842-1852. PubMed ID: 31071223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro.
    Yamamoto S; Sasahara K; Domon M; Yamaguchi K; Ito T; Goto S; Goto Y; Narita I
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33557434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.